Ranyelison Silva Machado

Ranyelison Silva Machado

Auto-generated profile, based on publicly available information

Ranyelison Silva Machado

Centro Universitário Uninassau

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
TST.M.Q. Seregheti
T.M.Q. Seregheti
APA.P.R. Pinto
A.P.R. Pinto
MGM.DA C. Gonçalves
M.DA C. Gonçalves
AAA.DOs S. Antunes
A.DOs S. Antunes
WAW.A.DA S. Almeida
W.A.DA S. Almeida
ANAndréa Mendes Do Nascimento
Andréa Mendes Do Nascimento
In this paper, we complement our previous study on the antiproliferative activity of Calea fruticosa (Asteraceae) by isolating the compounds apigenin-4',7-dimethyl ether (1), budlein A (2), quercetin (3), and cichoriin (4) from the plant’s aerial parts. The antiproliferative activity of these compounds was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method against human tumor cell lines. Compound 3 displayed moderate antiproliferative activity in three cell lines (HCT-116, PC-3, and SF-295, with cell growth inhibition values of 72.97, 74.55, and 68.94%) and high antiproliferative activity (90.86%) in the HL-60 cell line. The in vitro sun protection factor (SPF) of the extracts and compound 4, with and without sunscreen, was determined by a spectrophotometric method. The ethanol extract exhibited the highest SPF (9.67) at a concentration of 0.100 mg/mL, while compound 4, isolated from this extract, showed a SPF of 13.79 at the same concentration. A relative increased efficacy of SPF was observed for the extracts and compound 4 when sunscreen was also used. Compound 4 has not been reported previously from any species within the genus Calea. Compounds 1–4 were obtained from this species for the first time.

27 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ARAldenora Maria Ximenes Rodrigues
Aldenora Maria Ximenes Rodrigues
RCRayla Kelly Magalhães Costa
Rayla Kelly Magalhães Costa
RMRanyelison Silva Machado
Ranyelison Silva Machado
SGStanley Juan Chavez Gutierrez
Stanley Juan Chavez Gutierrez
FLFrancisco das Chagas Alves Lima
Francisco das Chagas Alves Lima
AOAldeídia Pereira de Oliveira
Aldeídia Pereira de Oliveira
The process involved in the research, discovery and development of drugs is characterized by high extensive and complex cost linked to scientific and technological innovations, and it is necessary to study and verify the progress of research carried out in the field that results in patent applications. Aniba riparia (Nees) Mez is a plant species often used for therapeutic purposes, where its pharmacological properties are associated to the presence of alkaloids called riparins. 5 synthetic analog compounds (riparins A, B, C, D, E and F) were developed from natural riparins. These molecules, natural and synthetic, showed several pharmacological activities in tests performed in vitro and in vivo , highlighting the Central Nervous System (CNS). The objective of this work was to evaluate the physical-chemical, pharmacokinetic parameters (absorption, distribution, metabolism, excretion and toxicity) and pharmacodynamic parameters (bioactivity and adverse reactions) of Riparin B by means of in silico computational prediction. Online software such as Pre-ADMET, SwissADME, Molinspiration and PASS on line were used for the analysis. Riparin B fits the characteristics of druglikeness , pharmacokinetic properties appropriate to the predicted patterns and activities within the scope for the treatment of AD, demonstrating a possible potential in the inhibition of AChE. Therefore, in silico results allow us to conclude that riparin B is predicted to be a potential future drug candidate, especially via oral administration, due to its relevant Drug-likeness profile, bioavailability, excellent liposolubility and adequate pharmacokinetics, including at the level of CNS, penetrating the blood-brain barrier.

18 June 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
BSBruno Nascimento Sales
Bruno Nascimento Sales
GSGrasyele Oliveira Sousa
Grasyele Oliveira Sousa
RMRanyelison Silva Machado
Ranyelison Silva Machado
GRGabriel Mauriz de Moura Rocha
Gabriel Mauriz de Moura Rocha
GOGuilherme Antônio Lopes de Oliveira
Guilherme Antônio Lopes de Oliveira
Objetivo: avaliar o perfil epidemiológico da hanseníase nas regiões Norte e Nordeste do Brasil entre os anos de 2015 e 2018. Metodologia: trata-se de uma pesquisa epidemiológica descritiva, retrospectiva e com abordagem quantitativa. Os dados mostram a caracterização epidemiológica quanto ao sexo, faixa etária e classificação operacional dos casos confirmados de hanseníase nas regiões Norte e Nordeste do Brasil entre os anos de 2015 e 2018. Resultados: a avaliação dos dados epidemiológicos apontou o total de 63.051 casos diagnosticados de hanseníase nas regiões Norte e Nordeste no período analisado. Ao investigar o perfil dos casos confirmados de hanseníase, observou-se que 56% ocorreram no sexo masculino, a faixa etária mais acometida foi de 35 a 49 anos, equivalente a 28% dos casos, seguida dos indivíduos de 50 a 64 anos (25%) e de 20 a 34 anos (20%) e a classificação operacional mais incidente foi a multibacilar (74%). Conclusão: os achados refletem a necessidade de capacitação contínua dos profissionais de saúde que prestam assistência aos pacientes com hanseníase e o fortalecimento das ações de vigilância e controle epidemiológico.

18 June 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ASAcácio Costa Silva
Acácio Costa Silva
MPMaria Caroline da Silva Paulo
Maria Caroline da Silva Paulo
MSMaria Jaqueline Oliveira Silva
Maria Jaqueline Oliveira Silva
RMRanyelison Silva Machado
Ranyelison Silva Machado
GRGabriel Mauriz de Moura Rocha
Gabriel Mauriz de Moura Rocha
GOGuilherme Antônio Lopes de Oliveira
Guilherme Antônio Lopes de Oliveira
Objetivo: Caracterizar a importância das abelhas sem ferrão e os estudos de atividade antimicrobiana e toxicidade de méis de Melipona rufiventris e Melipona fasciculata. Metodologia: Foi realizado revisão bibliográfica nas bases de dados: Scientific Electronic Library Online (SciElo), Google Acadêmico e PubMed. Sendo selecionados artigos, monografias, dissertações e teses, datados entre 2005 a 2020, nos idiomas inglês, português e espanhol. A busca foi realizada por meio dos descritores: mel, toxicidade, agentes antimicrobianos, Melipona rufiventris e Melipona fasciculata. E os artigos duplicados, incompletos foram excluídos da pesquisa. Resultados: Alguns estudos especificam a atividade antimicrobiana dos méis a determinadas substâncias, citando o peróxido de hidrogênio, metil-glioxal, hidroximetilfurfural, ácidos fenólicos, flavonóides e defensinas, como principais agentes antibacteriano e antifúngico. Em relação ao potencial tóxico, faz alusão de que os equipamentos utilizados para a coleta e o manejo do mel são considerados as principais fontes de contaminação por microrganismos patogênicos, aumentando consideravelmente o perfil microbiológico. Conclusão: Para as atividades antimicrobianas e antifúngicas, deve-se, que são geralmente associadas a substâncias como o peróxido de hidrogênio, metil-glioxal, hidroximetilfurfural, ácidos fenólicos, flavonóides e defensinas. Além disso, as evidências acerca do potencial tóxico desse produto estão relacionadas às fontes de contaminação por microrganismos patogênicos.

9 April 2020
Verified
Book Chapter
Closed access
PDF file
ACAna Amélia de Carvalho Melo Cavalcante
Ana Amélia de Carvalho Melo Cavalcante
ACAntônia Maria das Graças Lopes Citó
Antônia Maria das Graças Lopes Citó
MMMaria das Graças Freire de Medeiros
Maria das Graças Freire de Medeiros
MPMárcia Fernanda Correia Jardim Paz
Márcia Fernanda Correia Jardim Paz
MBMaria dos Remédios Mendes Brito
Maria dos Remédios Mendes Brito
WMWilliam Caracas Moreira
William Caracas Moreira

24 March 2026 in Cytotechnology
Verified
Journal Article
Open access
BFBianca Zaia Franco Ferreira
Bianca Zaia Franco Ferreira
DPDiego Mauro Carneiro Pereira
Diego Mauro Carneiro Pereira
JOJessica Onyeisi
Jessica Onyeisi
RMRanyelison Silva Machado
Ranyelison Silva Machado
RTRodrigo Esaki Tamura
Rodrigo Esaki Tamura
CLCarla Lopes
Carla Lopes
Many tumor cells exhibit resistance to anoikis, facilitating their invasion and contributing to tumor metastasis. Previous studies have shown that anoikis-resistant endothelial cells overexpress syndecan-4 (SDC4), a co-receptor for growth factors that interacts with extracellular matrix (ECM) proteins. While SDC4 is well-known for its role in cellular processes such as adhesion, migration, and proliferation, its specific involvement in cell cycle dysregulation in tumor cells remains poorly understood. This study aimed to investigate the role of SDC4 in regulating the cell cycle in anoikis-resistant endothelial cells. Methods included the use of wild-type endothelial cells (EC), EJ-ras oncogene-transfected EC (EJ-ras EC), anoikis-resistant EC (Adh1-EC), and SDC4-silenced EC (miR-Syn-4-1-Adh-EC). Gene and protein expression of regulatory molecules across different phases of the cell cycle were analyzed using qPCR, western blotting, and flow cytometry. The Integrated Biomarker Response (IBR) index was employed to interpret cellular responses, and cell viability was assessed after adhesion blockade. Results showed that while cyclin D1 was highly expressed in the G1 phase, SDC4-silenced cells exhibited increased p27 expression, which impairs the activity of the cyclin E-CDK2 complex, suggesting a potential hindrance to cell cycle progression. Additionally, a reduction in cyclin B1 expression was observed. The IBR index for cyclins and CDKs was 2.19 and 3.24, respectively, following SDC4 silencing, compared to 4.72 and 4.41 in anoikis-resistant cells. Furthermore, SDC4 silencing increased the cells’ susceptibility to anoikis. These findings highlight SDC4’s ability to modulate key processes involved in cancer development, emphasizing its potential as a therapeutic target in cancer treatment.